Skip to main content
Journal cover image

De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.

Publication ,  Journal Article
Kearney, E; Collins, T; Sengupta, S
Published in: Headache
July 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Headache

DOI

EISSN

1526-4610

Publication Date

July 2020

Volume

60

Issue

7

Start / End Page

1435 / 1437

Location

United States

Related Subject Headings

  • Vision Disorders
  • Neurology & Neurosurgery
  • Migraine without Aura
  • Migraine with Aura
  • Middle Aged
  • Humans
  • Female
  • Calcitonin Gene-Related Peptide
  • Antibodies, Monoclonal, Humanized
  • 3209 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kearney, E., Collins, T., & Sengupta, S. (2020). De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache, 60(7), 1435–1437. https://doi.org/10.1111/head.13855
Kearney, Elizabeth, Timothy Collins, and Sweta Sengupta. “De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.Headache 60, no. 7 (July 2020): 1435–37. https://doi.org/10.1111/head.13855.
Kearney E, Collins T, Sengupta S. De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache. 2020 Jul;60(7):1435–7.
Kearney, Elizabeth, et al. “De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm.Headache, vol. 60, no. 7, July 2020, pp. 1435–37. Pubmed, doi:10.1111/head.13855.
Kearney E, Collins T, Sengupta S. De Novo Visual Aura Onset in a Migraineur on Galcanezumab-Gnlm. Headache. 2020 Jul;60(7):1435–1437.
Journal cover image

Published In

Headache

DOI

EISSN

1526-4610

Publication Date

July 2020

Volume

60

Issue

7

Start / End Page

1435 / 1437

Location

United States

Related Subject Headings

  • Vision Disorders
  • Neurology & Neurosurgery
  • Migraine without Aura
  • Migraine with Aura
  • Middle Aged
  • Humans
  • Female
  • Calcitonin Gene-Related Peptide
  • Antibodies, Monoclonal, Humanized
  • 3209 Neurosciences